S
QGENF

SignatureFD’s QIAGEN NV QGENF Stock Holding History

SignatureFD’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-736
Closed -$20K – 1600
2016
Q3 		$20K Buy
736
+122
+20% +$3.31K ﹤0.01% 830
2016
Q2 		$13K Buy
614
+220
+56% +$4.66K ﹤0.01% 856
2016
Q1 		$9K Sell
394
-108
-22% -$2.47K ﹤0.01% 876
2015
Q4 		$14K Buy
502
+151
+43% +$4.21K ﹤0.01% 670
2015
Q3 		$9K Buy
+351
New +$9K ﹤0.01% 708

Other funds holding QGENF

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SignatureFD's QGENF Position: Q4 2016 in Review

SignatureFD sold out of QIAGEN NV (QGENF) in Q4 2016, closing a stake of 736 shares — an estimated $20K sold.

SignatureFD first reported a position in QGENF in Q3 2015 and held it in 5 quarters. The position peaked at $20K in Q3 2016. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

  • SignatureFD reported no remaining QIAGEN NV position as of Q4 2016 after selling out during the quarter.
  • SignatureFD sold 736 QIAGEN NV shares in Q4 2016, an estimated $20K.
  • SignatureFD first reported a position in QIAGEN NV in Q3 2015 and held it in 5 quarters.
  • SignatureFD's QIAGEN NV position peaked at $20K in Q3 2016.
  • 189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on SignatureFD's 13F filing for Q4 2016, filed 14 Feb 2017.